Shuai Zhen

3PUBLICATIONS
0CO-AUTHORS
Haematological tumoursReproductionPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 30, 2023
CRISPR/Cas9 for hepatitis B virus infection treatment.

Bo Cai, Shixue Chang, Yuhan Tian

|Feb 03, 2023
Intravaginal delivery for CRISPR-Cas9 technology: For example, the treatment of HPV infection.

Shuai Zhen, Hong Chen, Jiaojiao Lu

|Sep 19, 2022
CRISPR/Cas9-HPV-liposome enhances antitumor immunity and treatment of HPV infection-associated cervical cancer.

Shuai Zhen, Rong Qiang, Jiaojiao Lu

Pageof 1

Frequent Collaborators